VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
RYAN
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
RYANRyan Specialty Holdings, Inc.
$39.13$5.1B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksRYANQuarterly Financials

Ryan Specialty Holdings, Inc. (RYAN) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Ryan Specialty Holdings, Inc. (RYAN) quarterly income statement — complete revenue, gross profit & net income history

RYAN Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23
Revenue795.23M751.21M754.58M855.17M690.17M663.53M604.69M695.44M552.05M532.86M501.94M585.15M
Revenue Growth %15.22%13.21%24.79%22.97%25.02%24.52%20.47%18.85%20.64%22.49%21.83%19.1%
Medical Costs & Claims495.18M73.54M395.59M000000000
Medical Cost Ratio %62.27%9.79%52.43%0%0%0%0%0%0%0%0%0%
Gross Profit300.05M677.67M358.98M855.17M690.17M663.53M604.69M695.44M552.05M532.86M501.94M585.15M
Gross Margin %37.73%90.21%47.57%100%100%100%100%100%100%100%100%100%
Gross Profit Growth %-56.52%2.13%-40.63%22.97%25.02%24.52%20.47%18.85%20.64%22.49%21.83%19.1%
Operating Expenses205.46M542.77M203.35M717.44M639.13M594.49M585.01M558.71M504.94M473.69M461.41M489.68M
OpEx / Revenue %25.84%72.25%26.95%83.89%92.6%89.59%96.75%80.34%91.47%88.89%91.93%83.69%
Depreciation & Amortization073.54M73.8M72.56M67.62M63.1M41.65M32.81M30.07M30.14M31.77M26.55M
Combined Ratio %88.1%82.04%79.38%83.89%92.6%89.59%96.75%80.34%91.47%88.89%91.93%83.69%
Operating Income94.6M134.91M155.63M137.73M51.04M69.04M19.68M136.73M47.1M59.18M40.53M95.47M
Operating Margin %11.9%17.96%20.62%16.11%7.4%10.41%3.25%19.66%8.53%11.11%8.07%16.31%
Operating Income Growth %85.33%95.4%690.77%0.73%8.36%16.67%-51.44%43.22%10.18%14.59%23.98%17.44%
EBITDA94.6M208.45M229.43M210.29M118.67M132.14M61.33M169.54M77.17M89.32M72.3M122.01M
EBITDA Margin %11.9%27.75%30.4%24.59%17.19%19.91%10.14%24.38%13.98%16.76%14.4%20.85%
Interest Expense53.73M53.2M56.34M58.33M54.51M48.53M49.39M31.13M29.4M29.67M31.49M28.88M
Non-Operating Income037.1M37.17M-58.33M-54.51M-48.53M-49.39M-31.13M-29.4M-29.67M-31.49M-28.88M
Pretax Income47.1M44.61M59.81M137.73M51.04M69.04M19.68M136.73M47.1M59.18M40.53M95.47M
Pretax Margin %5.92%5.94%7.93%16.11%7.4%10.41%3.25%19.66%8.53%11.11%8.07%16.31%
Income Tax6.51M13.37M-2.8M13.03M55.43M26.49M-8.96M18.69M6.43M673K24.83M11.65M
Effective Tax Rate %13.82%29.97%-4.68%9.46%108.6%38.36%-45.54%13.67%13.64%1.14%61.26%12.2%
Net Income40.6M7.98M31.09M51.98M-27.64M13.75M17.59M46.79M16.54M22.85M-5.05M30.08M
Net Margin %5.11%1.06%4.12%6.08%-4.01%2.07%2.91%6.73%3%4.29%-1.01%5.14%
Net Income Growth %246.87%-41.98%76.73%11.09%-267.17%-39.8%448.5%55.55%25.65%27.67%-142.97%22.76%
EPS (Diluted)0.310.030.110.19-0.220.050.090.170.060.19-0.040.26
EPS Growth %240.91%-48.02%16.03%11.76%-471.62%-72.05%313.51%-34.62%-78.86%11.76%-140.36%18.18%
EPS (Basic)0.310.060.240.41-0.220.120.210.380.140.20-0.040.27
Diluted Shares Outstanding129.6M278.51M273.46M274.14M126.03M276.99M272.69M271.22M269.92M120.81M115.87M123.85M